Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Amylin at the crossroads of type 2 diabetes and neurodegenerative diseases, Ageing Research Reviews, 121 , (103226), (2026)
Metabolism 1978
With a 17 mg/mL vial, 5 mg 29 units
This resource helps you avoid obvious risks before you look at individual sites
Interaction with Strong CYP3A4/5 Inhibitors Strong CYP3A4/5 inhibitors can increase plasma concentrations of saxagliptin, potentially enhancing its pharmacological effects and adverse reactions
It also has not been approved by the European Medicines Agency or any other major health regulator in other countries
US$ 20.74
US$ 26.44
US$ 27.78
US$ 28.92
US$ 22.85
